We are monitoring the impact of COVID-19 on Latin America Thin Film Drugs Market Get in touch with us for detailed analysis Know More
Share on

Latin America Thin Film Drugs Market Research Report - Segmented By Product, Disease Indication, Distribution Channel & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 6198
Pages: 145

Latin America Thin Film Drugs Market Size & Growth (2022 to 2027):

As per the research report, the size of the Latin America Thin Film Drugs market is valued at USD 2.50 billion in 2022 and is expected to reach USD 3.94 billion by 2027 at a 9.56% CAGR during the forecast period 2022 to 2027.

The growing desire for an effective method of drug administration, as well as the limitations associated with traditional forms of dosing, are driving the industry forward.

One of the most important factors is that thin films are thought to be easy to swallow, self-administrable, and fast-dissolving dosage forms, making them a diverse platform for drug delivery.

Another critical element driving market expansion is pharmaceutical companies' increasing investments in research and development initiatives. These medications have a high therapeutic index and good physical features, including faster disintegration and dissolution. Furthermore, the oral thin film drug delivery technology avoids first-pass metabolism, increasing bioavailability.

Another critical factor is that, due to technological developments in these products, demand for thin-film pharmaceuticals has been increasing throughout Latin America. Therefore, numerous research and development efforts are underway to improve medicine delivery.

Intra-abdominal hypertension, for example, is defined as a pressure of more than 12 mmHg, which is the pressure at which organ failure develops. The normal intra-abdominal pressure (IAP) for seriously ill persons should be between 5-7 mmHg.

The treatment's high costs hamper the market's expansion. Furthermore, compared to traditional pharmaceuticals, the drugs effective therapeutic output gives a lucrative chance for the industry to flourish.

The availability of infrastructure and equipment in remote places is a rigid element. The lack of amenities for the underprivileged, who cannot afford to pay for their healthcare. The government should implement healthcare policies and programs.

This research report on the Latin America Thin Film Drugs Market has been segmented and sub-segmented into the following categories.

By Product: 

  • Oral Thin Film
  • Transdermal Thin Film

By Disease Indication:

  • Schizophrenia
  • Migraine
  • Opioid Dependence
  • Nausea and Vomiting

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Store
  • Retail Pharmacies
  • E-Commerce

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, Latin America has a moderate share of the worldwide market geographically due to the significant market adoption of novel drug delivery systems and the oral dosage form's superior therapeutic efficacy. In addition, the market share is boosted by robust product pipelines, extensive research activities, and widespread adoption of oral thin film medication delivery.

The Brazil Thin Film Drugs Market is likely to see considerable growth due to major pharmaceutical firms focusing their efforts on offering services to the region's vast and increasing populations.

Pharmaceutical research and development for identifying innovative medication delivery techniques are another essential geographical component that will drive the thin film drug market in the future by the rising demand for efficient drug delivery routes and their capability in the region. Furthermore, favorable government initiatives and an increase in the number of research partnerships are two factors that influence regional market growth.

The Mexico Thin Film Drugs Market has become a popular alternative to tablets and capsules due to their therapeutic effects. Polymers are used to make the drugs, which dissolve swiftly in the mouth or buccal cavity and reach the systemic circulation.

Lower thin film drug manufacturing costs, rising demand for effective drug delivery systems, and more research to generate novel polymeric thin films are projected to boost demand for thin-film pharmaceuticals regionally.

KEY MARKET PLAYERS

Prominent companies leading the Latin America Thin Film Drugs Market profiled in the report are Wolters Kluwer, Solvay, Allergan plc., IntelGenx Corp., ZIM Laboratories Limited, and IntelGenx Corp, Sumitomo Dainippon Pharma Co. Ltd., Indivior Plc., MonoSol Rx, Pfizer Inc., Novartis AG.,

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Oral Thin Film         

                                                5.1.2.1 Sublingual Film

                                                5.1.2.2 Fully Dissolving Dental/Buccal Film

                                5.1.3 Transdermal Thin Film        

                                5.1.4 Y-o-Y Growth Analysis, By Product               

                                5.1.5 Market Attractiveness Analysis, By Product             

                                5.1.6 Market Share Analysis, By Product               

                5.2 Disease Indication                   

                                5.2.1 Introduction           

                                5.2.2 Schizophrenia        

                                5.2.3 Migraine  

                                5.2.4 Opioid Dependence            

                                5.2.5 Nausea and Vomiting         

                                5.2.6 Y-o-Y Growth Analysis, By Disease Indication           

                                5.2.7 Market Attractiveness Analysis, By Disease Indication         

                                5.2.8 Market Share Analysis, By Disease Indication          

                5.3 Distribution Channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospital Pharmacies            

                                5.3.3 Drug Store               

                                5.3.4 Retail Pharmacies

                                5.3.5 E-Commerce          

                                5.3.6 Others      

                                5.3.7 Y-o-Y Growth Analysis, By Distribution Channel      

                                5.3.8  Market Attractiveness Analysis, By Distribution Channel   

                                5.3.9  Market Share Analysis, By Distribution Channel     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Disease Indication

                                                6.1.3.4 By Distribution Channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Disease Indication

                                                6.1.4.4 By Distribution Channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Disease Indication

                                                6.1.5.4 By Distribution Channel

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Pfizer Inc.                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis AG                

                8.3 Wolters Kluwer                         

                8.4 Solvay                           

                8.5 Allergan plc.                               

                8.6 Sumitomo Dainippon Pharma Co. Ltd.                            

                8.7 Indivior Plc.                 

                8.8 MonoSol Rx                

                8.9 IntelGenx Corp.                        

                8.10 ZIM Laboratories Limited                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  2. Latin America Oral Thin Film Market By Region, From 2022 to 2027 ( USD Billion )
  3. Latin America Transdermal Thin Film Market By Region, From 2022 to 2027 ( USD Billion )
  4. Latin America Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  5. Latin America Schizophrenia Market By Region, From 2022 to 2027 ( USD Billion )
  6. Latin America Migraine Market By Region, From 2022 to 2027 ( USD Billion )
  7. Latin America Opioid Dependence Market By Region, From 2022 to 2027 ( USD Billion )
  8. Latin America Nausea and Vomiting Market By Region, From 2022 to 2027 ( USD Billion )
  9. Latin America Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  10. Latin America Hospital Pharmacies Market By Region, From 2022 to 2027 ( USD Billion )
  11. Latin America Drug Store Market By Region, From 2022 to 2027 ( USD Billion )
  12. Latin America Retail Pharmacies  Market By Region, From 2022 to 2027 ( USD Billion )
  13. Latin America E-Commerce Market By Region, From 2022 to 2027 ( USD Billion )
  14. Brazil Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  15. Brazil Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  16. Brazil Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  17. Argentina Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  18. Argentina Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  19. Argentina Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  20. Mexico Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  21. Mexico Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  22. Mexico Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )
  23. Rest of Latin America Thin Film Drugs  Market By Product, From 2022 to 2027 ( USD Billion )
  24. Rest of Latin America Thin Film Drugs  Market By Disease Indication, From 2022 to 2027 ( USD Billion )
  25. Rest of Latin America Thin Film Drugs  Market By Distribution Channel, From 2022 to 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample